Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)

v3.22.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
Common Shares
Series1 Convertible Preferred Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020     $ 51,655,168 $ (50,731) $ (52,401,095) $ (796,658)
Balance at the beginning (in shares) at Dec. 31, 2020 4,828,846          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of special warrants (in shares) 270,326          
Share-based compensation     207,851     207,851
Foreign currency translation       (145,217)   (145,217)
Net loss         (6,334,854) (6,334,854)
Balance at the end at Jun. 30, 2021     51,863,019 (195,948) (58,735,949) (7,068,878)
Balance at the end (in shares) at Jun. 30, 2021 5,099,172          
Balance at the beginning at Mar. 31, 2021     51,733,845 (104,106) (58,510,406) (6,880,667)
Balance at the beginning (in shares) at Mar. 31, 2021 5,099,172          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation     129,174     129,174
Foreign currency translation       (91,842)   (91,842)
Net loss         (225,543) (225,543)
Balance at the end at Jun. 30, 2021     51,863,019 (195,948) (58,735,949) (7,068,878)
Balance at the end (in shares) at Jun. 30, 2021 5,099,172          
Balance at the beginning at Dec. 31, 2021     68,039,178 (187,919) (62,191,201) $ 5,660,058
Balance at the beginning (in shares) at Dec. 31, 2021 7,195,529         7,195,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation     240,277     $ 240,277
Conversion of convertible debt and derivative liability to Series 1 Convertible Preferred Shares     5,600,000     5,600,000
Conversion of convertible debt and derivative liability to Series 1 Convertible Preferred Shares (in shares)   70,000,000        
Foreign currency translation       49,477   49,477
Net loss         (4,839,883) (4,839,883)
Balance at the end at Jun. 30, 2022     73,879,455 (138,442) (67,031,084) $ 6,709,929
Balance at the end (in shares) at Jun. 30, 2022 7,195,529 70,000,000       7,195,529
Balance at the beginning at Mar. 31, 2022     68,164,043 (140,078) (64,286,046) $ 3,737,919
Balance at the beginning (in shares) at Mar. 31, 2022 7,195,529          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of special warrants     5,600,000     5,600,000
Conversion of special warrants (in shares)   70,000,000        
Share-based compensation     115,412     115,412
Foreign currency translation       1,636   1,636
Net loss         (2,745,038) (2,745,038)
Balance at the end at Jun. 30, 2022     $ 73,879,455 $ (138,442) $ (67,031,084) $ 6,709,929
Balance at the end (in shares) at Jun. 30, 2022 7,195,529 70,000,000       7,195,529